[SCHEDULE 13G/A] enVVeno Medical Corp Amended Passive Investment Disclosure
enVVeno: Kingdon reports 36,166 shares (5.5%)
enVVeno Medical Corporation reports a Schedule 13G/A amendment showing Kingdon-related parties beneficially own 36,166 shares, representing 5.5% of the common stock.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
enVVeno Medical Corporation reports a Schedule 13G/A amendment showing Kingdon-related parties beneficially own 36,166 shares, representing 5.5% of the common stock. The filing lists Kingdon Capital Management, L.L.C., M. Kingdon Offshore Master Fund, L.P., Kingdon GP, LLC and Mark Kingdon each with shared voting and dispositive power over 36,166 shares. Signatures show the filing was executed by Richard Weinstein and Mark Kingdon on 05/15/2026.
Insights
Kingdon-affiliated entities report a passive >5% stake in enVVeno.
The Schedule 13G/A lists 36,166 shares and a 5.5% ownership percentage for each reporting person, with shared voting and dispositive power. This presentation is consistent with an institutional investor reporting aggregated client positions.
Filing mechanics and signature blocks are complete; subsequent filings could update position if trades occur.
Shared voting/dispositive power is disclosed; beneficial ownership is disclaimed except for pecuniary interest.
The filing explicitly states advisory clients directly own the securities and that reporting persons disclaim beneficial ownership beyond pecuniary interest. The disclosure clarifies that only M. Kingdon Offshore Master Fund L.P. may be deemed >5% individually.
Investors tracking beneficial owners should note the filing’s joint-filer structure and the attached exhibits identifying control persons.
Key Figures
Reported shares:36,166 sharesPercent of class:5.5%CUSIP:29415J205
3 metrics
Reported shares36,166 sharesAmount beneficially owned by each reporting person
Percent of class5.5%Percent of common stock represented by 36,166 shares
CUSIP29415J205Common Stock CUSIP listed on the filing
"Amendment No. 1 ) enVVeno Medical Corporation Common Stock"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Shared dispositive powerfinancial
"Shared Dispositive Power 36,166.00"
Beneficial ownershipregulatory
"Amount beneficially owned: Kingdon Capital Management, L.L.C. - 36,166"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Kingdon report in enVVeno (NVNO)?
Kingdon-affiliated filers report beneficial ownership of 36,166 shares, representing 5.5% of the common stock. The filing lists shared voting and dispositive power for that share count.
Which Kingdon entities are named in the Schedule 13G/A?
Kingdon Capital Management, L.L.C., M. Kingdon Offshore Master Fund, L.P., Kingdon GP, LLC and Mark Kingdon are listed with the same reported share count and ownership percentage.
Does the filing state who actually owns the reported securities?
The filing states the securities are directly owned by advisory clients of Kingdon Capital Management, L.L.C., and that reporting persons disclaim beneficial ownership except to their pecuniary interest.
When was the Schedule 13G/A executed and who signed it?
The signatures show the filing was executed on 05/15/2026, signed by Richard Weinstein and Mark Kingdon in their listed capacities.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
enVVeno Medical Corporation
(Name of Issuer)
Common Stock, $0.00001 par value
(Title of Class of Securities)
29415J205
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
29415J205
1
Names of Reporting Persons
Kingdon Capital Management, L.L.C.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
36,166.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
36,166.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
36,166.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.5 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
29415J205
1
Names of Reporting Persons
M. Kingdon Offshore Master Fund, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
36,166.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
36,166.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
36,166.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.5 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
29415J205
1
Names of Reporting Persons
Kingdon GP, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
36,166.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
36,166.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
36,166.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.5 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
29415J205
1
Names of Reporting Persons
Mark Kingdon
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
36,166.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
36,166.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
36,166.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.5 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
enVVeno Medical Corporation
(b)
Address of issuer's principal executive offices:
70 Doppler, Irvine, California 92618, United States of America
Item 2.
(a)
Name of person filing:
Kingdon Capital Management, L.L.C.
M. Kingdon Offshore Master Fund L.P.
Kingdon GP, LLC
Mark Kingdon
(b)
Address or principal business office or, if none, residence:
Kingdon Capital Management, L.L.C.
152 West 57th Street, 50th Floor
New York, New York 10019
United States of America
M. Kingdon Offshore Master Fund L.P.
c/o Kingdon Capital Management, L.L.C.
152 West 57th Street, 50th Floor
New York, New York 10019
United States of America
Kingdon GP, LLC
c/o Kingdon Capital Management, L.L.C.
152 West 57th Street, 50th Floor
New York, New York 10019
United States of America
Mark Kingdon
c/o Kingdon Capital Management, L.L.C.
152 West 57th Street, 50th Floor
New York, New York 10019
United States of America
(c)
Citizenship:
Kingdon Capital Management, L.L.C. - Delaware
M. Kingdon Offshore Master Fund L.P. - Cayman Islands
Kingdon GP, LLC - Delaware
Mark Kingdon - United States
(d)
Title of class of securities:
Common Stock, $0.00001 par value
(e)
CUSIP No.:
29415J205
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Kingdon Capital Management, L.L.C. - 36,166
M. Kingdon Offshore Master Fund L.P. - 36,166
Kingdon GP, LLC - 36,166
Mark Kingdon - 36,166
(b)
Percent of class:
Kingdon Capital Management, L.L.C. - 5.5%
M. Kingdon Offshore Master Fund L.P. - 5.5%
Kingdon GP, LLC - 5.5%
Mark Kingdon - 5.5%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Kingdon Capital Management, L.L.C. - 0
M. Kingdon Offshore Master Fund L.P. - 0
Kingdon GP, LLC - 0
Mark Kingdon - 0
(ii) Shared power to vote or to direct the vote:
Kingdon Capital Management, L.L.C. - 36,166
M. Kingdon Offshore Master Fund L.P. - 36,166
Kingdon GP, LLC - 36,166
Mark Kingdon - 36,166
(iii) Sole power to dispose or to direct the disposition of:
Kingdon Capital Management, L.L.C. - 0
M. Kingdon Offshore Master Fund L.P. - 0
Kingdon GP, LLC - 0
Mark Kingdon - 0
(iv) Shared power to dispose or to direct the disposition of:
Kingdon Capital Management, L.L.C. - 36,166
M. Kingdon Offshore Master Fund L.P. - 36,166
Kingdon GP, LLC - 36,166
Mark Kingdon - 36,166
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
All of the securities reported in this Schedule 13G are directly owned by advisory clients of Kingdon Capital Management, L.L.C. None of those advisory clients, other than M. Kingdon Offshore Master Fund L.P., may be deemed to beneficially own more than 5% of the Common Stock, $0.00001 par value.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
Please see Exhibit B attached hereto.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Kingdon Capital Management, L.L.C.
Signature:
/s/ Richard Weinstein
Name/Title:
Richard Weinstein, Chief Operating Officer & General Counsel
Date:
05/15/2026
M. Kingdon Offshore Master Fund, L.P.
Signature:
By: Kingdon GP, LLC, its general partner, By: /s/ Mark Kingdon
Name/Title:
Mark Kingdon, Managing Member
Date:
05/15/2026
Kingdon GP, LLC
Signature:
/s/ Mark Kingdon
Name/Title:
Mark Kingdon, Managing Member
Date:
05/15/2026
Mark Kingdon
Signature:
/s/ Mark Kingdon
Name/Title:
Mark Kingdon
Date:
05/15/2026
Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information
Exhibit A - Joint Filing Agreement
Exhibit B - Control Person Identification
